|
Ranbaxy contemplating dropping Sidmak
acquisition
New Delhi: Indias most successful pharma company, Ranbaxy Laborataries, is said
to be contemplating dropping the acquisition of New Jersey (US) based, Sidmak
Laborataries. Sidmak, which is largely NRI owned, is one of the top ten generic pharma
companies in the US with a portfolio of over 100 products and manufacturing facilities in
the east. The company currently has a joint venture with Wockhardt to market over 15
products of the Indian company in the US.
Ranbaxy,
which had earlier initiated discussions with the US company for acquiring it, is said to
have developed second thoughts on the acquisition of the company. It is said the the New
Delhi based company would rather take its discovery molecules further at this stage.
Back to News
Review index page
Maruti may
post lower profit this year
New Delhi: For the second consecutive year running, the countrys show piece auto
company, Maruti Udyog Limited, may post a lower profit. Rising costs due to the
appreciation of the yen against the dollar is said to be the main contributing factor to
this low profit.
Besides, the company has also made huge investments
for capacity expansion, automation and setting up of a new press shop. It has also
introduced two new models this year. To add to its woes, the government directive that all
vehicle manufacturers should meet the Euro-II norms, forced the company to go in for major
overhaul of the engines.
Back to News
Review index page
HLL to enter
foods and vegetables in a big way
Mumbai: In an attempt to leverage on the distribution and cold-storage network of
Modern Foods, which it took over recently, consumer products and foods giant, Hindustan
Lever Limited, is said to be entering the horticulture business in a big way.
Already into the processed foods business, HLL plans
to take its foray into foods greater by getting into fresh foods and vegetables which will
ride piggy back on the Modern Foods distribution network and which will be branded as per
the existing brands it has.
Back to News
Review index page
Reliance said to
be considering stake in Hirma power project
New Delhi: Reliance Industries Limited, the countrys largest private sector
company, is said to be actively looking at the 3,690MW Hirma power project being developed
by the US-based Southern Electric Company in Orissa.
Reliance has a MoU with Southern Electric for development
of power projects in this country and, in light of that association, the company is said
to be looking at the Orissa project with the long term in mind.
Back to News
Review index page
GM may consider
producing Vectra
Bangalore: In a report appearing in the Business Line, Mr. Rajeev Chaba, vice
president of the company, is quoted as saying that the model is being seriously consider
manufacturing the high end Vectra model for the domestic market. The company, which is
currently selling the model for the import market, is contemplating pricing the car at Rs.
14 lakhs.
The company is to invest an additional Rs. 160 crore
over the next few years to upgrade its manufacturing facilities and is also sure to
introduce another model by the end of this year.
Back to News
Review index page
Family feud
hits Hyundai
Seoul: The Hyundai group, by far
the largest and the richest industrial group of South Korea, was caught in the midst of a
leadership struggle as two sons of the groups founder were locked in a dispute over
the control of the group.
The problem arose when the groups patriarch, 84
year old ailing Chung Ju-yung, announced that he had dismissed the elder son Chung
Mong-koo, who is currently co-chairman, and instead replaced him with a younger son, Chung
Mong-hun. The younger sibling, who is considered to be the more astute businessman among
the two, is in control of the best companies in the group that include Hyundai Engineering
and Construction, Hyundai Electronics and Hyundai Marine.
The family feud is likely to further depress the share
prices of the Hyundai group which are already under pressure of the last few years.
Back to News Review
index page
|